APA (7th ed.) Citation

M, B., & C, B. (2023). Authors' Reply to Ganijee et al: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults". Clinical pharmacokinetics, 62(11), 1651. https://doi.org/10.1007/s40262-023-01304-9

Chicago Style (17th ed.) Citation

M, Boettcher, and Becker C. "Authors' Reply to Ganijee Et Al: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults"." Clinical Pharmacokinetics 62, no. 11 (2023): 1651. https://doi.org/10.1007/s40262-023-01304-9.

MLA (9th ed.) Citation

M, Boettcher, and Becker C. "Authors' Reply to Ganijee Et Al: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults"." Clinical Pharmacokinetics, vol. 62, no. 11, 2023, p. 1651, https://doi.org/10.1007/s40262-023-01304-9.